Secondary hormonal manipulations in the treatment of castration refractory prostate cancer

BJU Int. 2011 Jul;108(2):227-8. doi: 10.1111/j.1464-410X.2010.09970.x. Epub 2010 Nov 24.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Androgens / metabolism
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Clinical Trials, Phase II as Topic
  • Humans
  • Ketoconazole / therapeutic use*
  • Male
  • Prostate-Specific Antigen / metabolism
  • Prostatic Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • Androgen Antagonists
  • Androgens
  • Antineoplastic Agents, Hormonal
  • Prostate-Specific Antigen
  • Ketoconazole